▶ 調査レポート

消化管病原体検査のグローバル市場(2023年-2031年):細菌、ウイルス、寄生虫

• 英文タイトル:Gastrointestinal Pathogen Testing Market (Pathogen Type: Bacteria, Viruses, and Parasites; Test Type: Molecular Tests, Culture, Biochemical Tests, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが調査・発行した産業分析レポートです。消化管病原体検査のグローバル市場(2023年-2031年):細菌、ウイルス、寄生虫 / Gastrointestinal Pathogen Testing Market (Pathogen Type: Bacteria, Viruses, and Parasites; Test Type: Molecular Tests, Culture, Biochemical Tests, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 / MRC2403B245資料のイメージです。• レポートコード:MRC2403B245
• 出版社/出版日:Transparency Market Research / 2023年12月
• レポート形態:英文、PDF、264ページ
• 納品方法:受注後3営業日
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥869,250 (USD5,795)▷ お問い合わせ
  Multi User¥1,319,250 (USD8,795)▷ お問い合わせ
  Corporate License¥1,769,250 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
消化管病原体検査市場 - レポートの範囲TMRの調査レポート「消化管病原体検査の世界市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界の消化管病原体検査t市場の収益を提供します。また、2023年から2031年までの世界の消化管病原体検査市場の複合年間成長率(CAGR %)も掲載しています。

本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、消化管病原体検査市場を理解した。

二次調査には、インターネット情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界の消化管病原体検査市場の様々な属性を調査しました。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、同レポートは、世界の消化管病原体検査市場における競争ダイナミクスの変化に光を投げかけています。これらは、既存の市場プレイヤーだけでなく、世界の消化管病原体検査市場への参入に関心のある企業にとっても貴重なツールとなります。

本レポートでは、世界の消化管病原体検査市場の競争環境について掘り下げています。世界の消化管病原体検査市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の消化管病原体検査市場のプレイヤーの属性です。

世界の消化管病原体検査市場レポートで回答された主な質問
- 予測期間中の全地域における胃腸病原体検査tの売上高/収益は?
- 世界の消化管病原体検査市場におけるビジネスチャンスは?
- 市場の主な促進要因、阻害要因、機会、脅威は何か?
- 予測期間中に最も速いCAGRで拡大する地域市場はどこか?
- 2031年に世界で最も高い収益を上げると予測されるセグメントは?
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは?
- 世界市場で事業を展開する各企業の市場ポジションは?

消化管病原菌検査市場 - 調査目的と調査アプローチ
消化管病原体検査の世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーや流通業者、製品承認のための規制シナリオについて詳細に解説しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴えます。また、過去と予測期間末の主要セグメントの市場シェアの比較も可能です。

当レポートでは、世界の消化管病原体検査市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察は、市場関係者が世界の消化管病原体検査市場への投資のための情報に基づいたビジネス上の意思決定を行うことを可能にします。

1. 序論
2. 仮定・調査手法
3. エグゼクティブサマリー:世界の消化管病原体検査市場
4. 市場概要
5. 主要インサイト
6. 世界の消化管病原体検査市場分析:病原体タイプ別
7. 世界の消化管病原体検査市場分析:検査タイプ
8. 世界の消化管病原体検査市場分析:パネルタイプ別
9. 世界の消化管病原体検査市場分析:エンドユーザー別
10. 世界の消化管病原体検査市場分析:地域別
11. 北米の消化管病原体検査市場分析
12. ヨーロッパの消化管病原体検査市場分析
13. アジア太平洋の消化管病原体検査市場分析
14. 中南米の消化管病原体検査市場分析
15. 中東/アフリカの消化管病原体検査市場分析
16. 競争状況

レポート目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Gastrointestinal Pathogen Testing Market
4. Market Overview
    4.1. Overview
    4.2. Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Opportunities
    4.3. Global Gastrointestinal Pathogen Testing Market Value Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Gastrointestinal Disorders: Overview
    5.2. Technological Advancements
    5.3. Key Industry Events (Key Developments, Partnership, Collaborations etc.)
    5.4. Overview of the test type conducted across each of the End users
    5.5. COVID-19 Pandemic Impact on Industry
6. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type
    6.1. Introduction
    6.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Pathogen Type
    6.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Pathogen Type
    6.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Pathogen Type
    6.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
        6.5.1. Bacteria
            6.5.1.1. Molecular Tests
            6.5.1.2. Culture
            6.5.1.3. Biochemical Tests
            6.5.1.4. Others
        6.5.2. Viruses
            6.5.2.1. Molecular Tests
            6.5.2.2. Culture
            6.5.2.3. Others
        6.5.3. Parasites
            6.5.3.1. Ova and Parasite Microscopy
            6.5.3.2. Molecular Tests
            6.5.3.3. Others
7. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type
    7.1. Introduction
    7.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Test Type
    7.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Test Type
    7.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Test Type
    7.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Test Type
        7.5.1. Molecular Tests
        7.5.2. Culture
        7.5.3. Biochemical Tests
        7.5.4. Others
8. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type
    8.1. Introduction
    8.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Panel Type
    8.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Panel Type
    8.4. Global Gastrointestinal Pathogen Testing Market Analysis, by Panel Type
    8.5. Global Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
        8.5.1. Syndromic Full Multiplex Panels
        8.5.2. Others
9. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user
    9.1. Introduction
    9.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by End-user
    9.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by End-user
    9.4. Global Gastrointestinal Pathogen Testing Market Analysis, by End-user
    9.5. Global Gastrointestinal Pathogen Testing Market Forecast, by End-user
        9.5.1. Hospitals
            9.5.1.1. Public
            9.5.1.2. Private
            9.5.1.3. Others
        9.5.2. Diagnostic Laboratories
        9.5.3. Point-of-Care
        9.5.4. Others
10. Global Gastrointestinal Pathogen Testing Market Analysis, by Region
    10.1. Introduction
    10.2. Global Gastrointestinal Pathogen Testing Market Share Analysis, by Region
    10.3. Global Gastrointestinal Pathogen Testing Market Attractiveness Analysis, by Region
    10.4. Global Gastrointestinal Pathogen Testing Market Forecast, by Region
        10.4.1. North America
        10.4.2. Europe
        10.4.3. Asia Pacific
        10.4.4. Latin America
        10.4.5. Middle East & Africa
11. North America Gastrointestinal Pathogen Testing Market Analysis
    11.1. Key Insights: North America Gastrointestinal Pathogen Testing Market
    11.2. North America Gastrointestinal Pathogen Testing Market Overview
    11.3. North America Gastrointestinal Pathogen Testing Market Forecast, by Country
        11.3.1. U.S.
        11.3.2. Canada
    11.4. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
    11.5. North America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
        11.5.1. Bacteria
            11.5.1.1. Molecular Tests
            11.5.1.2. Culture
            11.5.1.3. Biochemical Tests
            11.5.1.4. Others
        11.5.2. Viruses
            11.5.2.1. Molecular Tests
            11.5.2.2. Culture
            11.5.2.3. Others
        11.5.3. Parasites
            11.5.3.1. Ova and Parasite Microscopy
            11.5.3.2. Molecular Tests
            11.5.3.3. Others
    11.6. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
    11.7. North America Gastrointestinal Pathogen Testing Market Forecast, by Test Type
        11.7.1. Molecular Tests
        11.7.2. Culture
        11.7.3. Biochemical Tests
        11.7.4. Others
    11.8. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
    11.9. North America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
        11.9.1. Syndromic Full Multiplex Panels
        11.9.2. Others
    11.10. North America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
    11.11. North America Gastrointestinal Pathogen Testing Market Forecast, by End-user
        11.11.1. Hospitals
            11.11.1.1. Public
            11.11.1.2. Private
            11.11.1.3. Others
        11.11.2. Diagnostic Laboratories
        11.11.3. Point-of-Care
        11.11.4. Others
12. Europe Gastrointestinal Pathogen Testing Market Analysis
    12.1. Key Insights: Europe Gastrointestinal Pathogen Testing Market
    12.2. Europe Gastrointestinal Pathogen Testing Market Overview
    12.3. Europe Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
        12.3.1. Germany
        12.3.2. U.K.
        12.3.3. France
        12.3.4. Italy
        12.3.5. Spain
        12.3.6. Rest of Europe
    12.4. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
    12.5. Europe Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
        12.5.1. Bacteria
            12.5.1.1. Molecular Tests
            12.5.1.2. Culture
            12.5.1.3. Biochemical Tests
            12.5.1.4. Others
        12.5.2. Viruses
            12.5.2.1. Molecular Tests
            12.5.2.2. Culture
            12.5.2.3. Others
        12.5.3. Parasites
            12.5.3.1. Ova and Parasite Microscopy
            12.5.3.2. Molecular Tests
            12.5.3.3. Others
    12.6. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
    12.7. Europe Gastrointestinal Pathogen Testing Market Forecast, by Test Type
        12.7.1. Molecular Tests
        12.7.2. Culture
        12.7.3. Biochemical Tests
        12.7.4. Others
    12.8. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
    12.9. Europe Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
        12.9.1. Syndromic Full Multiplex Panels
        12.9.2. Others
    12.10. Europe Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
    12.11. Europe Gastrointestinal Pathogen Testing Market Forecast, by End-user
        12.11.1. Hospitals
            12.11.1.1. Public
            12.11.1.2. Private
            12.11.1.3. Others
        12.11.2. Diagnostic Laboratories
        12.11.3. Point-of-Care
        12.11.4. Others
13. Asia Pacific Gastrointestinal Pathogen Testing Market Analysis
    13.1. Key Insights: Asia Pacific Gastrointestinal Pathogen Testing Market
    13.2. Asia Pacific Gastrointestinal Pathogen Testing Market Overview
    13.3. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
        13.3.1. China
        13.3.2. Japan
        13.3.3. India
        13.3.4. Australia & New Zealand
        13.3.5. Rest of Asia Pacific
    13.4. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
    13.5. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
        13.5.1. Bacteria
            13.5.1.1. Molecular Tests
            13.5.1.2. Culture
            13.5.1.3. Biochemical Tests
            13.5.1.4. Others
        13.5.2. Viruses
            13.5.2.1. Molecular Tests
            13.5.2.2. Culture
            13.5.2.3. Others
        13.5.3. Parasites
            13.5.3.1. Ova and Parasite Microscopy
            13.5.3.2. Molecular Tests
            13.5.3.3. Others
    13.6. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
    13.7. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Test Type
        13.7.1. Molecular Tests
        13.7.2. Culture
        13.7.3. Biochemical Tests
        13.7.4. Others
    13.8. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
    13.9. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
        13.9.1. Syndromic Full Multiplex Panels
        13.9.2. Others
    13.10. Asia Pacific Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
    13.11. Asia Pacific Gastrointestinal Pathogen Testing Market Forecast, by End-user
        13.11.1. Hospitals
            13.11.1.1. Public
            13.11.1.2. Private
            13.11.1.3. Others
        13.11.2. Diagnostic Laboratories
        13.11.3. Point-of-Care
        13.11.4. Others
14. Latin America Gastrointestinal Pathogen Testing Market Analysis
    14.1. Key Insights: Latin America Gastrointestinal Pathogen Testing Market
    14.2. Latin America Gastrointestinal Pathogen Testing Market Overview
    14.3. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
        14.3.1. Brazil
        14.3.2. Mexico
        14.3.3. Rest of Latin America
    14.4. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
    14.5. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
        14.5.1. Bacteria
            14.5.1.1. Molecular Tests
            14.5.1.2. Culture
            14.5.1.3. Biochemical Tests
            14.5.1.4. Others
        14.5.2. Viruses
            14.5.2.1. Molecular Tests
            14.5.2.2. Culture
            14.5.2.3. Others
        14.5.3. Parasites
            14.5.3.1. Ova and Parasite Microscopy
            14.5.3.2. Molecular Tests
            14.5.3.3. Others
    14.6. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
    14.7. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Test Type
        14.7.1. Molecular Tests
        14.7.2. Culture
        14.7.3. Biochemical Tests
        14.7.4. Others
    14.8. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
    14.9. Latin America Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
        14.9.1. Syndromic Full Multiplex Panels
        14.9.2. Others
    14.10. Latin America Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
    14.11. Latin America Gastrointestinal Pathogen Testing Market Forecast, by End-user
        14.11.1. Hospitals
            14.11.1.1. Public
            14.11.1.2. Private
            14.11.1.3. Others
        14.11.2. Diagnostic Laboratories
        14.11.3. Point-of-Care
        14.11.4. Others
15. Middle East & Africa Gastrointestinal Pathogen Testing Market Analysis
    15.1. Key Insights: Middle East & Africa Gastrointestinal Pathogen Testing Market
    15.2. Middle East & Africa Gastrointestinal Pathogen Testing Market Overview
    15.3. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Country/Sub-region
        15.3.1. GCC Countries
        15.3.2. South Africa
        15.3.3. Rest of Middle East & Africa
    15.4. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Pathogen Type
    15.5. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Pathogen Type
        15.5.1. Bacteria
            15.5.1.1. Molecular Tests
            15.5.1.2. Culture
            15.5.1.3. Biochemical Tests
            15.5.1.4. Others
        15.5.2. Viruses
            15.5.2.1. Molecular Tests
            15.5.2.2. Culture
            15.5.2.3. Others
        15.5.3. Parasites
            15.5.3.1. Ova and Parasite Microscopy
            15.5.3.2. Molecular Tests
            15.5.3.3. Others
    15.6. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Test Type
    15.7. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Test Type
        15.7.1. Molecular Tests
        15.7.2. Culture
        15.7.3. Biochemical Tests
        15.7.4. Others
    15.8. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by Panel Type
    15.9. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by Panel Type
        15.9.1. Syndromic Full Multiplex Panels
        15.9.2. Others
    15.10. Middle East & Africa Gastrointestinal Pathogen Testing Market Share & Attractiveness Analysis, by End-user
    15.11. Middle East & Africa Gastrointestinal Pathogen Testing Market Forecast, by End-user
        15.11.1. Hospitals
            15.11.1.1. Public
            15.11.1.2. Private
            15.11.1.3. Others
        15.11.2. Diagnostic Laboratories
        15.11.3. Point-of-Care
        15.11.4. Others
16. Competition Landscape
    16.1. Market Player – Competition Matrix (by tier and size of companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. bioMérieux SA
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Becton, Dickinson, and Company (BD)
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. QIAGEN
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Bio-Rad Laboratories, Inc.
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Thermo Fisher Scientific, Inc.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Meridian Bioscience, Inc.
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Cepheid (Danaher Corporation)
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Laboratory Corporation of America Holdings
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Illumina, Inc.
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. DiaSorin S.p.A.
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. Seegene, Inc.
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview
        16.3.12. CerTest Biotec, S.L.
            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.12.2. Product Portfolio
            16.3.12.3. Financial Overview
            16.3.12.4. SWOT Analysis
            16.3.12.5. Strategic Overview
        16.3.13. Abbott
            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.13.2. Product Portfolio
            16.3.13.3. Financial Overview
            16.3.13.4. SWOT Analysis
            16.3.13.5. Strategic Overview
        16.3.14. F. Hoffmann-La Roche Ltd.
            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.14.2. Product Portfolio
            16.3.14.3. Financial Overview
            16.3.14.4. SWOT Analysis
            16.3.14.5. Strategic Overview
        16.3.15. Genova Diagnostics
            16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.15.2. Product Portfolio
            16.3.15.3. Financial Overview
            16.3.15.4. SWOT Analysis
            16.3.15.5. Strategic Overview
        16.3.16. MicroGen DX
            16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.16.2. Product Portfolio
            16.3.16.3. Financial Overview
            16.3.16.4. SWOT Analysis
            16.3.16.5. Strategic Overview
        16.3.17. Quidel Corporation
            16.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.17.2. Product Portfolio
            16.3.17.3. Financial Overview
            16.3.17.4. SWOT Analysis
            16.3.17.5. Strategic Overview



グローバル市場調査レポート販売サイトを運営しているマーケットリサーチセンター株式会社です。